Please wait a minute...
Frontiers of Medicine

ISSN 2095-0217

ISSN 2095-0225(Online)

CN 11-5983/R

Postal Subscription Code 80-967

2018 Impact Factor: 1.847

Front. Med.    2015, Vol. 9 Issue (3) : 344-349    https://doi.org/10.1007/s11684-015-0399-6
RESEARCH ARTICLE
Pathogenesis sequences in Gejiu miners with lung cancer: an introduction
Li Bian1,Yonghua Ruan2,Liju Ma3,Hairong Hua2,Li Zhou4,Xiaoyu Tuo1,Zheyan Zhou5,Ting Li1,Shiyue Liu1,Kewei Jin2,*()
1. Department of Pathology, The First Affiliated Hospital of Kunming Medical University, Kunming 650032, China
2. Department of Pathology, Kunming Medical University, Kunming 650031, China
3. Department of Clinical Medicine Research, The First Affiliated Hospital of Kunming Medical University, Kunming 650032, China
4. Department of Oncology, The Seventh People’s Hospital of Shanghai, Shanghai 200137, China
5. Department of Pathology, The Third People’s Hospital of Yunnan Province, Kunming 650011, China
 Download: PDF(1269 KB)   HTML
 Export: BibTeX | EndNote | Reference Manager | ProCite | RefWorks
Abstract

Tin miners in Gejiu, Yunnan Province, China are at high risk of developing lung cancer with significant occupational characteristics. Tissue samples from these miners presented pathological characteristics, such as fibroplasia in carcinomas, peri-cancerous tissue in lung cancers, and hyperplasia and dysplasia of epithelial cells in peri-cancerous tissue. Carcinomas induced by Yunnan tin mine dust in the animal experiment underwent inflammation, fibroplasia, hyperplasia, dysplasia, and carcinogenesis of epithelial cells. A correlated and synergistic relationship was observed between bronchial epithelial cell transformation and fibroblast activation in vitro induced by mine dust. Fibroblast hyperplasia and activation are important factors that promote the transformation and carcinogenesis of epithelial cells. Our findings suggested that pulmonary fibrosis may increase the risk and promote the occurrence of lung cancer, which can lead to lung fiber hyperplasia.

Keywords Yunnan tin mine      miners      lung cancer     
Corresponding Author(s): Kewei Jin   
Just Accepted Date: 08 June 2015   Online First Date: 08 July 2015    Issue Date: 26 August 2015
 Cite this article:   
Li Bian,Yonghua Ruan,Liju Ma, et al. Pathogenesis sequences in Gejiu miners with lung cancer: an introduction[J]. Front. Med., 2015, 9(3): 344-349.
 URL:  
https://academic.hep.com.cn/fmd/EN/10.1007/s11684-015-0399-6
https://academic.hep.com.cn/fmd/EN/Y2015/V9/I3/344
Fig.1  Mine dust deposition, clear fibroplasia, and fibrosis in peri-cancerous tissue. H&E stain 100×.
Fig.2  Alveolar type II epithelial hyperplasia and dysplasia and thickening of alveolar septum fiber. H&E stain 200×.
Fig.3  Excessive inflammation infiltration around the bronchioles at the early inhalation stage. H&E stain 200×.
Fig.4  Mine dust deposition following fibrosis hyperplasia; H&E stain 100×. Reprinted from Ref. [10] with permission.
Fig.5  Alveolar epithelia that show squamous metaplasia and dysplasia (★). H&E stain, 200×.
Fig.6  Squamous epithelial dysplasia and carcinoma in situ formation (★). H&E stain 200×.
Fig.7  ConA agglutination assay was positive in transformed epithelial cells exposed to mine dust. Inverted microscope 40×.
Fig.8  Anchorage-independent growth was positive in transformed epithelial cells exposed to mine dust (A) but negative in non-transformed epithelial cells (B). Inverted microscope 100×.
Fig.9  Immunohistochemical staining of α-SMA was positive in activated fibroblasts exposed to mine dust.
Fig.10  Induction of lung epithelial cell transformation and fibroblast activation by Yunnan tin mine dust and their interaction.
1 Zhang H, Yao SX, Zhou M, Mu YZ, Yang YC, Luo N, Yao MJ. Analysis of incidence and mortality of lung cancer among Yunnan tin miners from 2000 to 2004. J Occup Health Damage (Zhi Ye Wei Sheng Yu Bing Shang)2007; 22(1): 18-20 (in Chinese)
2 Yunnan Tin Miner's Lung Cancer Research Group. Etiological studies on Yunnan tin miner's lung cancer. Chin J Tuberc Respir Dis (Zhonghua Jie He He Hu Xi Za Zhi)1995; 18(1): 34-36 (in Chinese)
3 Jin KW, Gao Q, Sun LH, Liu CL, Yang Y. A study of the p53 tumor suppressor gene in Yunnan tin miner's lung carcinoma. Chin J Cancer (Ai Zheng) 1999; 18(1): 42-44(in Chinese)
4 Ruan YH, Jin KW, Gao Q, Hua HR, Zhou L, Liang R. Comparison of SP-B expression of lung cancer in Gejiu Miners with that in non-miners in other regions. Acad J Kunming Med Coll (Kunming Yi Xue Yuan Xue Bao)2004; (4): 6-9(in Chinese)
5 Huang Y, Jin K, Gao Q, Li B. p53 mutation in lung cancer in Gejiu and Xuanwei regions of Yunnan Province. J West China Univ Med Sci (Hua Xi Yi Ke Da Xue Xue Bao)2001; 32(3): 361-364 (in Chinese)
pmid: 12536564
6 Ruan YH, Gao Q, Zhang L, Hua HR, Cheng JL, Jin KW. Loss of exons of FHIT protein expression in Yunnan tin miners with lung cancer. Chin J Cancer (Ai Zheng)2007; 26(6): 607-612 (in Chinese)
7 Jin KW, Zeng J, Gao Q, Sun LH, Wang GY, Liu CL. A study of in situ hybridization of N-ras、c-myc and c-fos in Yunnan tin miner's lung carcinoma. Chin J Ind Hyg Occup Dis (Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi)1998; 16(5): 285-287 (in Chinese)
8 Hua HR, Jin KW, Ruan YH, Gao Q. Expression and aberrant methylation of DAPK gene of lung cancer tissues in Yunnan tin miners. Chin Occup Med (Zhongguo Zhi Ye Yi Xue)2007; 34(2): 87-89 (in Chinese)
9 Jiang P, Jin KW, Gao Q. Comparison of TGFβ1 expression of lung cancer in Gejiu miners with that in non-miners in other regions. Chin J Ind Hyg Occup Dis (Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi)2004; 22(1): 36-38 (in Chinese)
10 Ruan YH, Hua HR, Gao Q, Song JL, Liang R, Jin KW. Pathological study of lung cancer induced by Yunnan tin mine dusts in F344 rats. Chin J Ind Hyg Occup Dis (Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi)2007; 25(6): 331-335 (in Chinese))
pmid: 17723188
11 Ruan YH, Jin KW. Detection of related genetic alterations in lung cancer among Yunnan tin miners and study on an animal model of lung cancer with Yunnan Tin Mineral dust in F344 rats. Doctoral Dissertation. Kunming: Kunming Medical University, 2005
12 Bian L, Jin KW. Study on the Interaction between malignant transformation of human pulmonary epithelial cells and activation of fibroblasts induced by Yunnan tin mine dust and the mechanisms. Doctoral Dissertation. Kunming: Kunming Medical of University, 2008
13 Bian L, He YW, Tang RZ, Ma LJ, Wang CY, Ruan YH, Gao Q, Jin KW. Induction of lung epithelial cell transformation and fibroblast activation by Yunnan tin mine dust and their interaction. Med Oncol 2011; 28(Suppl 1): S560-S569
https://doi.org/10.1007/s12032-010-9655-4 pmid: 20717754
14 Zhou L, Jin KW. The Study on the Malignant transformation of immortalized human bronchial epithelial cells BEAS-2B induced by tin mine dust in Yunnan Province. Doctoral Dissertation. Kunming: Kunming Medical University, 2006
15 Zhou L, Jin KW, Zhang TB. Expression of P53, MDM2, P21, P16 in malignant transformation cells of human bronchial epithelial cells induced by Yunnan tin mines dust. J Environ Occup Med (Huan Jing Yu zhi Ye Yi Xue)2007; 24(3): 319-321 (in Chinese)
16 Bian L, He YW, Fu HM, Ruan YH, Gao Q, Wang CY, Jin KW. Expression of fragile histidine triad (FHIT) protein and Ki-67 in transformed epithelial cells induced by Yunnan tin mine dust. Chin J Ind Hyg Occup Dis (Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi)2010; 28(12): 895-899 (in Chinese)
pmid: 21241597
[1] Jiahui Xu, Qianqian Wang, Elaine Lai Han Leung, Ying Li, Xingxing Fan, Qibiao Wu, Xiaojun Yao, Liang Liu. Compound C620-0696, a new potent inhibitor targeting BPTF, the chromatin-remodeling factor in non-small-cell lung cancer[J]. Front. Med., 2020, 14(1): 60-67.
[2] Zhao Zhang, Jun Jiang, Xiaodong Wu, Mengyao Zhang, Dan Luo, Renyu Zhang, Shiyou Li, Youwen He, Huijie Bian, Zhinan Chen. Chimeric antigen receptor T cell targeting EGFRvIII for metastatic lung cancer therapy[J]. Front. Med., 2019, 13(1): 57-68.
[3] Kohei Miyazono, Yoko Katsuno, Daizo Koinuma, Shogo Ehata, Masato Morikawa. Intracellular and extracellular TGF-β signaling in cancer: some recent topics[J]. Front. Med., 2018, 12(4): 387-411.
[4] Dalin Zhang, Liwei Qu, Bo Zhou, Guizhen Wang, Guangbiao Zhou. Genomic variations in the counterpart normal controls of lung squamous cell carcinomas[J]. Front. Med., 2018, 12(3): 280-288.
[5] Hongbing Shen. Low-dose CT for lung cancer screening: opportunities and challenges[J]. Front. Med., 2018, 12(1): 116-121.
[6] Alexandra Urman,H. Dean Hosgood. Curbing the burden of lung cancer[J]. Front. Med., 2016, 10(2): 228-232.
[7] Douglas D. Fang, Joan Cao, Jitesh P. Jani, Konstantinos Tsaparikos, Alessandra Blasina, Jill Kornmann, Maruja E. Lira, Jianying Wang, Zuzana Jirout, Justin Bingham, Zhou Zhu, Yin Gu, Gerrit Los, Zdenek Hostomsky, Todd VanArsdale. Combined gemcitabine and CHK1 inhibitor treatment induces apoptosis resistance in cancer stem cell-like cells enriched with tumor spheroids from a non-small cell lung cancer cell line[J]. Front Med, 2013, 7(4): 462-476.
[8] Yue Yu, Jie He. Molecular classification of non-small-cell lung cancer: diagnosis, individualized treatment, and prognosis[J]. Front Med, 2013, 7(2): 157-171.
[9] Yize Xiao, Ying Shao, Xianjun Yu, Guangbiao Zhou. The epidemic status and risk factors of lung cancer in Xuanwei City, Yunnan Province, China[J]. Front Med, 2012, 6(4): 388-394.
[10] Ji Qi, David Mu. MicroRNAs and lung cancers: from pathogenesis to clinical implications[J]. Front Med, 2012, 6(2): 134-155.
[11] Min ZHU, Xiang-Ning FU, Xiao-Ping CHEN. Lobectomy by video-assisted thoracoscopic surgery (VATS) for early stage of non-small cell lung cancer[J]. Front Med, 2011, 5(1): 53-60.
[12] Dian-Ke YU PhD, Chen WU MD, Wen TAN MD, Dong-Xin LIN MD, . Functional XPF polymorphisms associated with lung cancer susceptibility in a Chinese population[J]. Front. Med., 2010, 4(1): 82-89.
[13] Bo PENG BA , Jinnong ZHANG MD , Jamile S. WOODS MD , Wei PENG MD, PhD . Molecular markers and pathogenically targeted therapy in non-small cell lung cancer[J]. Front. Med., 2009, 3(3): 245-255.
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed